161 related articles for article (PubMed ID: 7779404)
1. Structure-function relationships for the EGF/TGF-alpha family of mitogens.
Groenen LC; Nice EC; Burgess AW
Growth Factors; 1994; 11(4):235-57. PubMed ID: 7779404
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor contains both positive and negative determinants for interaction with ErbB-2/ErbB-3 heterodimers.
Stortelers C; van De Poll ML; Lenferink AE; Gadellaa MM; van Zoelen C; van Zoelen EJ
Biochemistry; 2002 Apr; 41(13):4292-301. PubMed ID: 11914075
[TBL] [Abstract][Full Text] [Related]
3. Contribution of the transforming growth factor alpha B-loop beta-sheet to binding and activation of the epidermal growth factor receptor.
Richter A; Drummond DR; MacGarvie J; Puddicombe SM; Chamberlin SG; Davies DE
J Biol Chem; 1995 Jan; 270(4):1612-6. PubMed ID: 7829492
[TBL] [Abstract][Full Text] [Related]
4. Non-linear antigenic regions in epidermal growth factor (EGF) and transforming growth factor alpha (TGF alpha) studied by EGF-TGF alpha chimaeras.
van de Poll ML; van Rotterdam W; Gadellaa MM; Stortelers C; van Vugt MJ; van Zoelen EJ
Biochem J; 2000 Jul; 349(Pt 1):267-74. PubMed ID: 10861238
[TBL] [Abstract][Full Text] [Related]
5. Identification of the high affinity binding site of transforming growth factor-alpha (TGF-alpha) for the chicken epidermal growth factor (EGF) receptor using EGF/TGF-alpha chimeras.
Kramer RH; Lenferink AE; van Bueren-Koornneef IL; van der Meer A; van de Poll ML; van Zoelen EJ
J Biol Chem; 1994 Mar; 269(12):8708-11. PubMed ID: 8132599
[TBL] [Abstract][Full Text] [Related]
6. The solution structures of epidermal growth factor and transforming growth factor alpha.
Campbell ID; Cooke RM; Baron M; Harvey TS; Tappin MJ
Prog Growth Factor Res; 1989; 1(1):13-22. PubMed ID: 2491252
[TBL] [Abstract][Full Text] [Related]
7. The chemical synthesis and binding affinity to the EGF receptor of the EGF-like domain of heparin-binding EGF-like growth factor (HB-EGF).
Shin SY; Yokoyama T; Takenouchi T; Munekata E
J Pept Sci; 2003 Apr; 9(4):244-50. PubMed ID: 12725245
[TBL] [Abstract][Full Text] [Related]
8. Chemical synthesis, structural modeling, and biological activity of the epidermal growth factor-like domain of human cripto.
Lohmeyer M; Harrison PM; Kannan S; DeSantis M; O'Reilly NJ; Sternberg MJ; Salomon DS; Gullick WJ
Biochemistry; 1997 Apr; 36(13):3837-45. PubMed ID: 9092813
[TBL] [Abstract][Full Text] [Related]
9. The significance of valine 33 as a ligand-specific epitope of transforming growth factor alpha.
Puddicombe SM; Chamberlin SG; MacGarvie J; Richter A; Drummond DR; Collins J; Wood L; Davies DE
J Biol Chem; 1996 Jun; 271(26):15367-72. PubMed ID: 8663070
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor alpha.
Kumar V; Bustin SA; McKay IA
Cell Biol Int; 1995 May; 19(5):373-88. PubMed ID: 7640654
[TBL] [Abstract][Full Text] [Related]
11. Structure-based minimization of transforming growth factor-alpha (TGF-alpha) through NMR analysis of the receptor-bound ligand. Design, solution structure, and activity of TGF-alpha 8-50.
McInnes C; Wang J; Al Moustafa AE; Yansouni C; O'Connor-McCourt M; Sykes BD
J Biol Chem; 1998 Oct; 273(42):27357-63. PubMed ID: 9765263
[TBL] [Abstract][Full Text] [Related]
12. The interaction of an epidermal growth factor/transforming growth factor alpha tail chimera with the human epidermal growth factor receptor reveals unexpected complexities.
Puddicombe SM; Wood L; Chamberlin SG; Davies DE
J Biol Chem; 1996 Nov; 271(48):30392-7. PubMed ID: 8940002
[TBL] [Abstract][Full Text] [Related]
13. Colorectum cell-derived growth factor (CRDGF) is homologous to amphiregulin, a member of the epidermal growth factor family.
Culouscou JM; Remacle-Bonnet M; Carlton GW; Plowman GD; Shoyab M
Growth Factors; 1992; 7(3):195-205. PubMed ID: 1333777
[TBL] [Abstract][Full Text] [Related]
14. Structural analysis of an epidermal growth factor/transforming growth factor-alpha chimera with unique ErbB binding specificity.
Wingens M; Walma T; van Ingen H; Stortelers C; van Leeuwen JE; van Zoelen EJ; Vuister GW
J Biol Chem; 2003 Oct; 278(40):39114-23. PubMed ID: 12869572
[TBL] [Abstract][Full Text] [Related]
15. Comparative studies of the mitogenic effects of epidermal growth factor and transforming growth factor-alpha and the expression of various growth factors in neoplastic and non-neoplastic prostatic cell lines.
Jones HE; Eaton CL; Barrow D; Dutkowski CM; Gee JM; Griffiths K
Prostate; 1997 Mar; 30(4):219-31. PubMed ID: 9111599
[TBL] [Abstract][Full Text] [Related]
16. Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha.
Reddy CC; Wells A; Lauffenburger DA
J Cell Physiol; 1996 Mar; 166(3):512-22. PubMed ID: 8600155
[TBL] [Abstract][Full Text] [Related]
17. Mutations within subdomain II of the extracellular region of epidermal growth factor receptor selectively alter TGF alpha binding.
Harte MT; Gentry LE
Arch Biochem Biophys; 1995 Oct; 322(2):378-89. PubMed ID: 7574711
[TBL] [Abstract][Full Text] [Related]
18. Ligand binding characterization and molecular analysis of distinct epidermal growth factor-urogastrone receptors in cultured smooth muscle and epithelial cells from guinea pig intestine.
Yang SG; Ahmad S; Wong NC; Hollenberg MD
Mol Pharmacol; 1994 Aug; 46(2):256-65. PubMed ID: 8078489
[TBL] [Abstract][Full Text] [Related]
19. Human betacellulin structure modeled from other members of EGF family.
López-Torrejón I; Querol E; Avilés FX; Seno M; de Llorens R; Oliva B
J Mol Model; 2002 Apr; 8(4):131-44. PubMed ID: 12111392
[TBL] [Abstract][Full Text] [Related]
20. Determination of receptor protein binding site specificity and relative binding strength using a time-resolved competition assay.
Barta P; Volkova M; Dascalu A; Spiegelberg D; Trejtnar F; Andersson K
J Pharmacol Toxicol Methods; 2014; 70(2):145-51. PubMed ID: 25084055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
